Adial Pharmaceuticals, Inc.
ADIL
$0.71
-$0.0051-0.71%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -157.60% | -114.95% | -57.04% | 2.11% | 42.33% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 33.33% | -97.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 761.78% | 1,009.25% | 881.81% | 188.56% | -151.45% |
| Change in Net Operating Assets | 148.63% | 158.79% | 69.88% | -722.59% | -55.09% |
| Cash from Operations | -1.70% | 8.78% | 31.67% | 44.17% | 39.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -69.57% | -12.50% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -69.57% | -12.50% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 945.55% | 946.16% | 617.75% | 550.44% | -91.78% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 89.87% | 1,400.48% | 1,172.41% | 1,101.46% | -54.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 178.61% | 189.91% | 126.07% | 126.14% | 42.99% |
